Stuart Schwartz, PhD, FACMG

Consultant, Cytogenetics · Laboratory Corporation of America · company speakers →

Dr. Schwartz has published over 180 peer reviewed journal articles and 24 invited chapters. He is a past president of the American Board of Medical Genetics and more recently on the Board and a past president of the Cancer Cytogenomics Consortium. He is also a former Cytogenetics section editor for both the American Journal of Medical Genetics and for Genetics in Medicine and has been a reviewer for numerous journals. He was honored as the 2018 recipient of the American Cytogenetics Conference Distinguished Cytogeneticist Award. Dr. Schwartz has extensive experience in cytogenetics, FISH and microarray analysis and has been instrumental in the development of the microarray studies at CMBP involving postnatal, prenatal, products of conceptions and oncology specimens. Most of his more recent work involves implementation and improvement of microarray analysis in the clinical laboratory. Over the course of his career he has been responsible for the training of over 25 students and postdocs mostly in clinical cytogenetics and molecular cytogenetics

pharma-biotechhealthcare-servicesclinical-laboratorymedical-devices

Is this you? Claim this profile →

No public contact links on file.

Speaking history

ACMG Annual Clinical Genetics Meeting

13 April 2027 Minneapolis, United States “Speed Mentoring Sessions”

Topics this speaker covers

pharma-biotechhealthcare-servicesclinical-laboratorymedical-devices

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →